4//SEC Filing
PLATT PHILLIP JOHN 4
Accession 0001567619-23-004548
CIK 0001653477other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 7:30 PM ET
Size
21.3 KB
Accession
0001567619-23-004548
Insider Transaction Report
Form 4
Ingevity CorpNGVT
PLATT PHILLIP JOHN
SVP, Finance & CAO
Transactions
- Exercise/Conversion
Common Stock
2023-03-02$27.90/sh+2,288$63,835→ 10,811 total - Sale
Common Stock
2023-03-02$81.70/sh−2,288$186,930→ 8,523 total - Exercise/Conversion
Common Stock
2023-03-02$53.11/sh+1,207$64,104→ 9,730 total - Sale
Common Stock
2023-03-02$81.63/sh−1,207$98,527→ 8,523 total - Exercise/Conversion
Common Stock
2023-03-02$45.04/sh+2,363$106,430→ 10,886 total - Sale
Common Stock
2023-03-02$81.62/sh−2,363$192,868→ 8,523 total - Sale
Common Stock
2023-03-02$81.83/sh−2,989$244,590→ 5,534 total - Exercise/Conversion
Employee Stock Option (right to buy)
2023-03-02−2,288→ 0 totalExercise: $27.90Exp: 2026-05-27→ Common Stock (2,288 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2023-03-02−1,207→ 0 totalExercise: $53.11Exp: 2027-02-27→ Common Stock (1,207 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2023-03-02−2,363→ 0 totalExercise: $45.04Exp: 2030-02-28→ Common Stock (2,363 underlying)
Footnotes (6)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.64 to $81.73, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.60 to $81.65, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.60 to $81.69, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The option, representing a right to purchase a total of 2,288 shares, became fully vested and exercisable on February 27, 2019.
- [F5]The option, representing a right to purchase a total of 1,207 shares, became fully vested and exercisable on February 27, 2020.
- [F6]The option, representing a right to purchase a total of 2,363 shares, became fully vested and exercisable on February 28, 2023.
Documents
Issuer
Ingevity Corp
CIK 0001653477
Entity typeother
Related Parties
1- filerCIK 0001668926
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 7:30 PM ET
- Size
- 21.3 KB